Momeneh Foroutan
Momeneh Foroutan
Monash University
Verified email at
Cited by
Cited by
Single sample scoring of molecular phenotypes
M Foroutan, DD Bhuva, R Lyu, K Horan, J Cursons, MJ Davis
BMC bioinformatics 19, 1-10, 2018
A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients
J Cursons, F Souza-Fonseca-Guimaraes, M Foroutan, A Anderson, ...
Cancer immunology research 7 (7), 1162-1174, 2019
Combinatorial targeting by microRNAs co-ordinates post-transcriptional control of EMT
J Cursons, KA Pillman, KG Scheer, PA Gregory, M Foroutan, ...
Cell systems 7 (1), 77-91. e7, 2018
A transcriptional program for detecting TGFβ-induced EMT in cancer
M Foroutan, J Cursons, S Hediyeh-Zadeh, EW Thompson, MJ Davis
Molecular Cancer Research 15 (5), 619-631, 2017
Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines
J Cursons, KJ Leuchowius, M Waltham, E Tomaskovic-Crook, M Foroutan, ...
Cell Communication and Signaling 13, 1-21, 2015
Removing unwanted variation from large-scale RNA sequencing data with PRPS
R Molania, M Foroutan, JA Gagnon-Bartsch, LC Gandolfo, A Jain, A Sinha, ...
Nature Biotechnology 41 (1), 82-95, 2023
The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome
M Foroutan, R Molania, A Pfefferle, C Behrenbruch, S Scheer, A Kallies, ...
Cancer Immunology Research 9 (10), 1125-1140, 2021
Using singscore to predict mutation status in acute myeloid leukemia from transcriptomic signatures
DD Bhuva, M Foroutan, Y Xie, R Lyu, J Cursons, MJ Davis
F1000Research 8, 2019
Tgfβ and cis inhibition overcomes NK-cell suppression to restore antitumor immunity
F Souza-Fonseca-Guimaraes, GR Rossi, LF Dagley, M Foroutan, ...
Cancer Immunology Research 10 (9), 1047-1054, 2022
CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation
AC Cheh, G Advani, M Foroutan, J Smith, N Ng, H Nandurkar, DS Lio, ...
Oncogene 40 (17), 3015-3029, 2021
Targeting WEE1/AKT Restores p53-dependent natural killer–cell activation to induce immune checkpoint blockade responses in “cold” melanoma
SS Dinavahi, YC Chen, K Punnath, A Berg, M Herlyn, M Foroutan, ...
Cancer immunology research 10 (6), 757-769, 2022
Synthetic epigenetic reprogramming of mesenchymal to epithelial states using the CRISPR/dCas9 platform in triple negative breast cancer
C Waryah, J Cursons, M Foroutan, C Pflueger, E Wang, R Molania, ...
Advanced Science 10 (22), 2301802, 2023
Structure analysis of genetic diversity in tetraploid and diploid cotton genotypes
Z Noormohammadi, E Taghavi, M Foroutan, M Sheidai, O Alishah
International Journal of Plant, Animal and Environmental Sciences 3 (1), 79-90, 2013
Networking and Bayesian analyses of genetic affinity in cotton germplasm
Z Noormohammadi, M Sheidai, M Foroutan, O Alishah
The Nucleus 58, 33-45, 2015
Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal Cancer
C Behrenbruch, M Foroutan, P Lind, J Smith, M Grandin, B Cooper, ...
BioRxiv, 2021.02. 04.429849, 2021
A natural killer cell gene signature predicts melanoma patient survival
J Cursons, F Souza-Fonseca-Guimaraes, A Anderson, M Foroutan, ...
bioRxiv, 375253, 2018
Post-transcriptional control of EMT is coordinated through combinatorial targeting by multiple microRNAs
J Cursons, KA Pillman, K Scheer, PA Gregory, M Foroutan, SH Zadeh, ...
bioRxiv, 138024, 2017
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
A Sgro, J Cursons, C Waryah, EA Woodward, M Foroutan, R Lyu, ...
Clinical Epigenetics 15 (1), 73, 2023
A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients
C Shembrey, M Foroutan, F Hollande
Frontiers in Immunology 13, 1011247, 2023
Computational screening of anti-cancer drugs identifies a new BRCA independent gene expression signature to predict breast cancer sensitivity to cisplatin
J Berthelet, M Foroutan, DD Bhuva, HJ Whitfield, F El-Saafin, J Cursons, ...
Cancers 14 (10), 2404, 2022
The system can't perform the operation now. Try again later.
Articles 1–20